Childhood onset nexilin dilated cardiomyopathy: A heterozygous and a homozygous case

Am J Med Genet A. 2021 Aug;185(8):2464-2470. doi: 10.1002/ajmg.a.62231. Epub 2021 May 5.

Abstract

Pathogenic heterozygous NEXN variants are associated with progressive dilated cardiomyopathy (DCM) usually presenting around 50 years of age. We describe an asymptomatic boy who had transient DCM at 3 months of age, that resolved by 4 months. Presently, at 11 years of age, he has normal cardiac function with signs of mild DCM on cardiac MRI. Genetic diagnostics revealed a paternally derived, heterozygous 1949_1951del class 4 variant in NEXN. His father had mild DCM with mildly reduced systolic function. The second patient presented with fetal hydrops at 33 weeks gestation requiring emergency caesarian delivery. Postnatally she required ventilation and continuous inotropic support for left ventricle systolic dysfunction. She died after 2 weeks when therapy was withdrawn. Homozygous c.1174C > T,p.(R392*) class 4 variants in the NEXN gene were found via WES. Microscopic investigation showed endomyocardial fibroelastosis. Her parents, both heterozygous carriers, had normal cardiac function and the family history was normal. These patients show a new clinical spectrum of pediatric cardiac disease seen in heterozygous and homozygous NEXN variants, ranging from mild, transient DCM to a severe, fatal neonatal DCM. These patients support the inclusion of the NEXN gene in the investigation of pediatric patients with DCM, even in cases with transient DCM.

Keywords: NEXN; dilated cardiomyopathy; nexilin.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Cardiomyopathy, Dilated / diagnosis*
  • Cardiomyopathy, Dilated / genetics*
  • Child
  • Electrocardiography
  • Fatal Outcome
  • Female
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Heterozygote*
  • Homozygote*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Microfilament Proteins / genetics*
  • Mutation*
  • Phenotype
  • Symptom Assessment

Substances

  • Microfilament Proteins
  • NEXN protein, human